Published in Transplantation on June 27, 2010
Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol (2014) 1.90
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76
Mesenchymal stem cell-based therapy. Mol Pharm (2012) 1.09
Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res (2013) 1.01
Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus. J Diabetes Res (2015) 0.95
Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med (2013) 0.93
Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. Mol Ther (2013) 0.92
Influence of microenvironment on engraftment of transplanted β-cells. Ups J Med Sci (2011) 0.91
Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front Endocrinol (Lausanne) (2014) 0.90
Cell-based therapies for diabetic complications. Exp Diabetes Res (2011) 0.90
MRI/SPECT/Fluorescent Tri-Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model. Adv Funct Mater (2015) 0.90
Genetically modified mesenchymal stem cells for improved islet transplantation. Mol Pharm (2011) 0.88
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol (2015) 0.86
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85
Cooperation by fibroblasts and bone marrow-mesenchymal stem cells to improve pancreatic rat-to-mouse islet xenotransplantation. PLoS One (2013) 0.84
Mesenchymal stem cells as feeder cells for pancreatic islet transplants. Rev Diabet Stud (2010) 0.84
Allogeneic bone marrow cocultured with human islets significantly improves islet survival and function in vivo. Transplantation (2013) 0.83
Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation. Pharm Res (2011) 0.83
Endothelial progenitor cell cotransplantation enhances islet engraftment by rapid revascularization. Diabetes (2012) 0.83
Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J Gastroenterol (2011) 0.83
Co-transplantation of endothelial progenitor cells and pancreatic islets to induce long-lasting normoglycemia in streptozotocin-treated diabetic rats. PLoS One (2014) 0.83
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant (2011) 0.83
A double mechanism for the mesenchymal stem cells' positive effect on pancreatic islets. PLoS One (2014) 0.82
Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice. PLoS One (2013) 0.82
The co-transplantation of bone marrow derived mesenchymal stem cells reduced inflammation in intramuscular islet transplantation. PLoS One (2015) 0.81
In vivo imaging of embryonic stem cell therapy. Eur J Nucl Med Mol Imaging (2010) 0.81
Bioengineering a highly vascularized matrix for the ectopic transplantation of islets. Islets (2013) 0.80
Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function. Curr Diab Rep (2012) 0.80
Stem cell-based strategies for the treatment of type 1 diabetes mellitus. Expert Opin Biol Ther (2010) 0.80
Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells. Stem Cells Transl Med (2014) 0.79
Engineering a local microenvironment for pancreatic islet replacement. Curr Opin Biotechnol (2013) 0.79
Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel. Biomaterials (2013) 0.79
Intravenous transplantation of very small embryonic like stem cells in treatment of diabetes mellitus. Avicenna J Med Biotechnol (2015) 0.79
Striated muscle as implantation site for transplanted pancreatic islets. J Transplant (2011) 0.79
Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. Sci Rep (2015) 0.79
Mesenchymal stem cells for inducing tolerance in organ transplantation. Front Cell Dev Biol (2014) 0.78
Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation. World J Gastroenterol (2014) 0.78
Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells (2014) 0.78
Mesobiliverdin IXα Enhances Rat Pancreatic Islet Yield and Function. Front Pharmacol (2013) 0.78
Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes. World J Stem Cells (2016) 0.78
A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem Cells. Tissue Eng Part C Methods (2015) 0.77
Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic mice. Pancreas (2011) 0.77
Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation. PLoS One (2013) 0.77
The efficacy of mesenchymal stem cell transplantation in caustic esophagus injury: an experimental study. Stem Cells Int (2014) 0.77
Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets. Dis Model Mech (2015) 0.77
The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation. Curr Diabetes Rev (2012) 0.77
Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site. Cell Med (2014) 0.77
Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic. Cell Death Discov (2016) 0.75
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells. Stem Cells Int (2016) 0.75
Coculturing Human Islets with Proangiogenic Support Cells to Improve Islet Revascularization at the Subcutaneous Transplantation Site. Tissue Eng Part A (2016) 0.75
β-MSCs: successful fusion of MSCs with β-cells results in a β-cell like phenotype. Oncotarget (2016) 0.75
Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis? Int J Endocrinol (2012) 0.75
Stem cells as a tool to improve outcomes of islet transplantation. J Transplant (2012) 0.75
Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus. Cell Med (2011) 0.75
Multimodal Imaging Reveals Improvement of Blood Supply to an Artificial Cell Transplant Site Induced by Bioluminescent Mesenchymal Stem Cells. Mol Imaging Biol (2017) 0.75
Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice. Stem Cell Res Ther (2017) 0.75
Integration of mesenchymal stem cells into islet cell spheroids improves long-term viability, but not islet function. Islets (2017) 0.75
Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment. Int J Endocrinol (2017) 0.75
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol (2009) 4.05
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood (2009) 2.91
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood (2008) 2.24
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood (2008) 2.23
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Insulin gene expression is regulated by DNA methylation. PLoS One (2009) 1.97
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes. Sci Transl Med (2012) 1.59
Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood (2005) 1.56
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem (2010) 1.42
HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen. Proc Natl Acad Sci U S A (2008) 1.41
Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. Cancer Res (2009) 1.37
A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J Immunol (2005) 1.37
Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol (2009) 1.25
Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant (2005) 1.24
Targeted destruction of DNA replication protein Cdc6 by cell death pathways in mammals and yeast. Mol Biol Cell (2002) 1.24
Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med (2013) 1.19
Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report. J Clin Endocrinol Metab (2014) 1.15
Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS One (2012) 1.14
Thyroid carcinoma. J Natl Compr Canc Netw (2007) 1.13
In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor. Bioconjug Chem (2011) 1.12
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Circ Res (2005) 1.12
In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. J Nucl Med (2013) 1.12
Thyroid carcinoma. J Natl Compr Canc Netw (2005) 1.04
Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proc Natl Acad Sci U S A (2007) 1.02
Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol (2012) 1.02
Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients. J Immunol (2011) 1.01
Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology (2004) 1.01
Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody. J Immunol (2007) 1.01
Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells. J Immunol (2013) 1.00
Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol (2005) 0.99
A prospective randomized comparison between pylorus- and subtotal stomach-preserving pancreatoduodenectomy on postoperative delayed gastric emptying occurrence and long-term nutritional status. J Surg Oncol (2014) 0.98
Medullary carcinoma. J Natl Compr Canc Netw (2010) 0.97
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI. Blood (2008) 0.96
Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease. J Immunol (2012) 0.96
Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease. J Immunol (2010) 0.96
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood (2004) 0.94
A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. J Gastrointest Surg (2011) 0.93
PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a. Aging Cell (2013) 0.92
18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol (2013) 0.91
Insulin sensitivity and insulin clearance are heritable and have strong genetic correlation in Mexican Americans. Obesity (Silver Spring) (2014) 0.89
Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation. Pancreas (2006) 0.88
Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation. Transplantation (2010) 0.88
Neuroendocrine tumor of vulva: a case report and review of literature. J Cancer Res Ther (2010) 0.87
Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs. Eur J Nucl Med Mol Imaging (2014) 0.87
Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys. Immunology (2005) 0.87
Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation (2002) 0.86
Human marrow-derived mesodermal progenitor cells generate insulin-secreting islet-like clusters in vivo. Stem Cells Dev (2007) 0.86
18F-labeled proteins. Curr Pharm Biotechnol (2010) 0.86
Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells. Cancer Lett (2003) 0.85
Liver natural killer cells play a role in the destruction of islets after intraportal transplantation. Transplantation (2011) 0.85
Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetes. Endocrinology (2009) 0.85
Radionuclide probes for molecular imaging of pancreatic beta-cells. Adv Drug Deliv Rev (2010) 0.85
Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor. Transplantation (2008) 0.84